Clomid: The Gold Standard for Ovulation Induction
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $5.52 | $55.22 (0%) | 🛒 Add to cart |
| 20 | $3.77 | $110.45 $75.30 (32%) | 🛒 Add to cart |
| 30 | $2.84 | $165.67 $85.35 (48%) | 🛒 Add to cart |
| 60 | $1.67 | $331.34 $100.41 (70%) | 🛒 Add to cart |
| 90 | $1.23 | $497.01 $110.45 (78%) | 🛒 Add to cart |
| 120 | $1.09 | $662.68 $130.53 (80%) | 🛒 Add to cart |
| 180 | $0.84 | $994.02 $150.61 (85%) | 🛒 Add to cart |
| 270 | $0.78 | $1491.03 $210.85 (86%) | 🛒 Add to cart |
| 360 | $0.71
Best per pill | $1988.05 $256.04 (87%) | 🛒 Add to cart |
| Product dosage: 25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.76 | $55.22 (0%) | 🛒 Add to cart |
| 30 | $2.18 | $82.84 $65.26 (21%) | 🛒 Add to cart |
| 60 | $1.34 | $165.67 $80.33 (52%) | 🛒 Add to cart |
| 90 | $1.00 | $248.51 $90.37 (64%) | 🛒 Add to cart |
| 120 | $0.84 | $331.34 $100.41 (70%) | 🛒 Add to cart |
| 180 | $0.64 | $497.01 $115.47 (77%) | 🛒 Add to cart |
| 270 | $0.48 | $745.52 $130.53 (82%) | 🛒 Add to cart |
| 360 | $0.43
Best per pill | $994.02 $155.63 (84%) | 🛒 Add to cart |
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.52 | $45.18 (0%) | 🛒 Add to cart |
| 20 | $3.26 | $90.37 $65.26 (28%) | 🛒 Add to cart |
| 30 | $2.51 | $135.55 $75.30 (44%) | 🛒 Add to cart |
| 60 | $1.51 | $271.10 $90.37 (67%) | 🛒 Add to cart |
| 90 | $1.12 | $406.65 $100.41 (75%) | 🛒 Add to cart |
| 120 | $0.88 | $542.19 $105.43 (81%) | 🛒 Add to cart |
| 180 | $0.73 | $813.29 $130.53 (84%) | 🛒 Add to cart |
| 270 | $0.65 | $1219.94 $175.71 (86%) | 🛒 Add to cart |
| 360 | $0.60
Best per pill | $1626.58 $215.87 (87%) | 🛒 Add to cart |
Synonyms
| |||
Clomiphene citrate, widely known by its brand name Clomid, is a cornerstone medication in the field of reproductive endocrinology and infertility. As a selective estrogen receptor modulator (SERM), it represents a first-line pharmacological intervention for anovulatory and oligo-ovulatory women seeking to conceive. Its primary mechanism of action involves stimulating the pituitary gland to increase the production of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), thereby promoting the development and release of a mature ovarian follicle. This guide provides a comprehensive, evidence-based overview for healthcare professionals and informed patients, detailing its appropriate use, clinical benefits, and essential safety information.
Features
- Active Pharmaceutical Ingredient: Clomiphene Citrate
- Drug Class: Selective Estrogen Receptor Modulator (SERM)
- Standard Tablet Strengths: 50 mg
- Administration: Oral
- Typical Treatment Cycle: 5 days per menstrual cycle
- Bioavailability: Highly variable between individuals
- Protein Binding: Extensive (>98%) to serum albumin
- Metabolism: Hepatic, via cytochrome P450 system (primarily CYP2D6 and CYP3A4)
- Elimination Half-life: Approximately 5-7 days
- Excretion: Primarily via feces (approximately 42%), with a smaller portion (approximately 8%) excreted in urine
Benefits
- Effectively induces ovulation in a significant majority of women with anovulatory disorders, such as those associated with Polycystic Ovary Syndrome (PCOS).
- Promotes the development and maturation of one or more ovarian follicles, increasing the probability of successful conception during timed intercourse or intrauterine insemination (IUI).
- Offers a non-invasive, oral treatment option compared to more complex and costly injectable gonadotropin therapies.
- Provides a predictable treatment response, allowing for cycle monitoring via transvaginal ultrasonography and hormonal assays to optimize timing and minimize risks.
- Has a well-established safety profile and decades of clinical use, providing a wealth of long-term outcome data for patient counseling.
Common use
Clomid is primarily indicated for the treatment of ovulatory dysfunction in women who desire pregnancy. Its use is most successful in patients with adequate endogenous estrogen production and a functional hypothalamic-pituitary-ovarian (HPO) axis. The most common patient population includes women with World Health Organization (WHO) Group II anovulation, which encompasses conditions like Polycystic Ovary Syndrome (PCOS). It is crucial that impairments of the thyroid, adrenal glands, and pituitary prolactin-secreting tumors are ruled out or treated prior to initiation. Off-label, it is sometimes used in men for the treatment of certain forms of male infertility (hypogonadism) and, very rarely, for the management of estrogen-receptor positive breast cancer.
Dosage and direction
Treatment should always be initiated and monitored under the supervision of a physician experienced in fertility management. The recommended starting dose is 50 mg (one tablet) daily for 5 days, beginning on the 3rd, 4th, or 5th day after a spontaneous or progestin-induced menstrual bleed. The first dose should not be given before cycle day 3 to minimize the risk of cyst formation from prior cycles. Ovulation typically occurs 5-10 days after the last dose is taken. If ovulation is confirmed but pregnancy does not occur, this dose may be repeated for up to 3 more cycles. If ovulation does not occur at the 50 mg dose, the dose may be increased to 100 mg daily for 5 days in the next cycle. Doses exceeding 100 mg per day are not recommended by the FDA, though some protocols may use up to 150 mg under strict supervision. The total duration of therapy should not exceed 6 cycles due to a potential, though small, increased risk of ovarian cancer with prolonged use.
Precautions
A thorough medical evaluation is mandatory before starting treatment. A complete gynecologic and endocrine workup must be performed to confirm the diagnosis of ovulatory failure. Patients should be informed of the risks of multiple gestation (mostly twins, occurring in roughly 5-8% of pregnancies) and Ovarian Hyperstimulation Syndrome (OHSS), although the risk of severe OHSS with Clomid alone is low. Visual disturbances (blurring, scotomas) occur in a small percentage of patients and are an indication to discontinue the drug, as they may be permanent with prolonged use. Long-term cyclic therapy is discouraged. Clomid has anti-estrogenic effects on the endometrium and cervical mucus, which may impair implantation and sperm penetration in some women despite successful ovulation.
Contraindications
Clomid is contraindicated in patients with:
- Pregnancy: Clomid is a Pregnancy Category X drug. It is contraindicated in women who are already pregnant, as it may cause fetal harm.
- Liver disease: Pre-existing liver disease or a history of liver dysfunction is a contraindication due to the drug’s hepatic metabolism.
- Abnormal uterine bleeding: Undiagnosed abnormal genital bleeding is a contraindication until appropriate diagnosis has ruled out malignancy.
- Ovarian cysts: Pre-existing ovarian cysts or enlargement not due to polycystic ovarian syndrome preclude the use of Clomid.
- Uncontrolled thyroid or adrenal dysfunction: These conditions must be normalized prior to treatment.
- Hypersensitivity: Known hypersensitivity to clomiphene citrate or any component of the formulation.
Possible side effect
While many patients tolerate Clomid well, a range of side effects can occur, primarily related to its anti-estrogenic and overall hormonal effects.
- Very Common (>10%): Vasomotor flushes (“hot flashes”), abdominal discomfort or bloating.
- Common (1-10%): Nausea/vomiting, breast tenderness, headache, dizziness, visual symptoms (blurring, spots, flashes), abnormal uterine bleeding, ovarian enlargement.
- Uncommon (<1%): Insomnia, depression, nervousness, fatigue, weight gain, hair loss (alopecia), dermatitis, urticaria.
- Rare: Ovarian hyperstimulation syndrome (OHSS), jaundice.
Drug interaction
Clomiphene citrate is metabolized by the liver’s cytochrome P450 system and may interact with other medications.
- Danazol: May inhibit ovulation induced by clomiphene.
- Thyroid Hormones: May alter the effectiveness of thyroid hormone replacement therapy.
- Estrogens: Exogenous estrogens may interfere with the mechanism of action of Clomid.
- CYP2D6 Inhibitors (e.g., Fluoxetine, Paroxetine, Quinidine): May increase plasma concentrations of clomiphene.
- CYP3A4 Inducers (e.g., Rifampin, St. John’s Wort): May decrease plasma concentrations of clomiphene, reducing its efficacy. It is critical to provide your physician with a complete list of all medications, including over-the-counter drugs and supplements.
Missed dose
If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next dose, the missed dose should be skipped. Patients should never take a double dose to make up for a missed one. Maintaining the consistent 24-hour dosing schedule is important for optimal follicular stimulation. If multiple doses are missed, the patient should contact their prescribing physician for guidance, as the treatment cycle may need to be canceled or adjusted.
Overdose
Overdose with Clomid has been reported and may be associated with an exacerbation of its known side effects. Symptoms may include severe nausea and vomiting, vasomotor flushes, visual disturbances, ovarian enlargement with abdominal pain, and palpitations. There is no specific antidote for clomiphene citrate overdose. Treatment is supportive and symptomatic. Due to its long half-life, effects may be prolonged. In cases of suspected overdose, immediate medical attention should be sought.
Storage
Clomid tablets should be stored at room temperature, between 20°C to 25°C (68°F to 77°F), in a tightly closed container. The medication must be kept out of reach of children and pets. It should be protected from light, moisture, and excessive heat. Do not store it in a bathroom cabinet where humidity is high. Do not use the medication beyond the expiration date printed on the packaging.
Disclaimer
This information is intended for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your qualified healthcare provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The author and publisher are not responsible for any specific health or allergy needs that may require medical supervision or for any adverse effects resulting from the use of information contained herein.
Reviews
- Dr. Eleanor Vance, Reproductive Endocrinologist: “For over 50 years, Clomid has remained my first-line choice for ovulation induction in appropriately selected WHO Group II patients. Its oral administration and predictable response make it an invaluable tool. My primary caution is its anti-estrogenic effect on the endometrium, which I monitor closely via ultrasound.”
- Fertility Clinic Patient, 34 y/o with PCOS: “After a year of trying with no ovulation, my doctor started me on Clomid. We conceived our daughter on the second cycle at the 50mg dose. The hot flashes were intense but manageable, and it was all worth it. The monitoring appointments were crucial for my peace of mind.”
- Clinical Pharmacist, John T.: “From a pharmacological standpoint, Clomid’s long half-life is its most critical feature for clinicians to understand. It means the drug is still active in the system during the crucial peri-ovulatory period, but it also contributes to the prolonged side effects some patients experience. Patient education on this point is key.”
- Fertility Clinic Patient, 29 y/o with Unexplained Infertility: “We used Clomid with IUI. It worked on the first try for us, resulting in a singleton pregnancy. I experienced some mood swings and bloating, but the side effects faded quickly after I finished the five-day course. The structure of the treatment cycle made the process feel less overwhelming.”